Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics
Boyer, Thomas D, Sanyal, Arun J, Garcia-Tsao, Guadalupe, Blei, Andres, Carl, Daniel, Bexon, Alice S, Teuber, Peter
Published in Journal of hepatology (01.08.2011)
Published in Journal of hepatology (01.08.2011)
Get full text
Journal Article
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
Cottu, Paul H, Bonneterre, Jacques, Varga, Andrea, Campone, Mario, Leary, Alexandra, Floquet, Anne, Berton-Rigaud, Dominique, Sablin, Marie-Paule, Lesoin, Anne, Rezai, Keyvan, Lokiec, François M, Lhomme, Catherine, Bosq, Jacques, Bexon, Alice S, Gilles, Erard M, Proniuk, Stefan, Dieras, Veronique, Jackson, David M, Zukiwski, Alexander, Italiano, Antoine
Published in PloS one (10.10.2018)
Published in PloS one (10.10.2018)
Get full text
Journal Article
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1
Boyer, Thomas D., Sanyal, Arun J., Garcia‐Tsao, Guadalupe, Regenstein, Frederick, Rossaro, Lorenzo, Appenrodt, Beate, Gülberg, Veit, Sigal, Samuel, Bexon, Alice S., Teuber, Peter
Published in Liver transplantation (01.11.2011)
Published in Liver transplantation (01.11.2011)
Get full text
Journal Article
Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity
Lewis, James H., Cottu, Paul H., Lehr, Martin, Dick, Evan, Shearer, Todd, Rencher, William, Bexon, Alice S., Campone, Mario, Varga, Andrea, Italiano, Antoine
Published in Drug safety (01.10.2020)
Published in Drug safety (01.10.2020)
Get full text
Journal Article
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy
Smith, David A., Conkling, Paul, Richards, Donald A., Nemunaitis, John J., Boyd, Thomas E., Mita, Alain C., de La Bourdonnaye, Guillaume, Wages, David, Bexon, Alice S.
Published in Cancer Immunology, Immunotherapy (01.08.2014)
Published in Cancer Immunology, Immunotherapy (01.08.2014)
Get full text
Journal Article
IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers
Vandergaast, Rianna, Carey, Timothy, Reiter, Samantha, Lathrum, Chase, Lech, Patrycja, Gnanadurai, Clement, Haselton, Michelle, Buehler, Jason, Narjari, Riya, Schnebeck, Luke, Roesler, Anne, Sevola, Kara, Suksanpaisan, Lukkana, Bexon, Alice, Naik, Shruthi, Brunton, Bethany, Weaver, Scott C, Rafael, Grace, Tran, Sheryl, Baum, Alina, Kyratsous, Christos A, Peng, Kah Whye, Russell, Stephen J
Published in mSphere (30.06.2021)
Published in mSphere (30.06.2021)
Get full text
Journal Article
505 Relationship of infusion duration and dose to safety, efficacy and pharmacodynamics: second part of a phase 1–2 study using VSV-IFNβ-NIS (VV1) oncolytic virus in patients with refractory solid tumors
Patel, Manish, Powell, Steven, Strauss, James, Johnson, Melissa, Cripe, Timothy, Peng, Kah-Whye, Russell, Stephen, Russell, Luke, Reckner, Monica, Wiegert, Erol, Bexon, Alice, Merchan, Jaime
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
422 Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma
Miest, Tanner, Leibovich, Bradley, Bardot, Stephen, Young, Paul, Boorjian, Stephen, Gonzalgo, Mark, Herrera-Hernandez, Loren, Tollefson, Matthew, Karnes, Jeffrey, Nichols, Paige, Kroeninger, Tessa, Graham, Rachel, Lahana, Carole, Reckner, Monica, Newsom, Alysha, Packiriswamy, Nandakumar, Anoka, Janice, Peng, Kah Whye, Wiegert, Erol, Bexon, Alice, Naik, Shruthi
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Phase 1b study results of IMO-2055, a novel TLR9 agonist, in combination with erlotinib (E) and bevacizumab (bev) in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC) who have progressed following prior chemotherapy
Smith, David A, Conkling, Paul, Richards, Donald A, Flores, Maria Regina C, Nemunaitis, John J, Boyd, Thomas E, Mita, Alain C, de La Bourdonnaye, Guillaume, Wages, David, Bexon, Alice S
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2012)
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2012)
Get full text
Journal Article
Irinotecan Combined With Bolus Fluorouracil, Continuous Infusion Fluorouracil, and High-Dose Leucovorin Every Two Weeks (LV5FU2 Regimen): A Clinical Dose-Finding and Pharmacokinetic Study in Patients With Pretreated Metastatic Colorectal Cancer
DUCREUX, M, YCHOU, M, SEITZ, J.-F, BONNAY, M, BEXON, A, ARMAND, J.-P, MAHJOUBI, M, MERY-MIGNARD, D, ROUGIER, P
Published in Journal of clinical oncology (01.09.1999)
Published in Journal of clinical oncology (01.09.1999)
Get full text
Journal Article
Abstract LB114: Tumor uptake and predictable PK of ST101 - a peptide antagonist of C/EBPβ - in patients with advanced unresectable and metastatic solid tumors
Falchook, Gerald, McKean, Meredith, Lakhani, Nehal, Arkenau, Tobias, Symeonides, Stefan, Evans, Jeff, Lim, Emerson, Rotolo, Jim, Michel, Rob, Bexon, Alice
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract CT044: AST-008, a TLR9 agonist spherical nucleic acid, activated NK cells, T cells, and cytokines in healthy subjects in a Phase I clinical trial
Daniel, Weston L., Lorch, Ulrike, Coates, Simon, Bexon, Alice S., Mix, Scott
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Preliminary pharmacokinetic and safety data after a single intravenous infusion of Voyager-V1 (VV1, VSV-IFNβ-NIS) oncolytic virus in patients with relapsed refractory hematologic malignancies
Peng, Kah Whye, Remick, Adam, Bennani, Nabila Nora, Cook, Joselle, Zhang, Lianwen, Witzig, Thomas E., Munoz, Javier, Broski, Stephen M, Geyer, Susan Michelle, Ginos, Brenda F., Russell, Luke, Bexon, Alice Susannah, Russell, Stephen J., Lacy, Martha
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
First-in-human phase I clinical trial of RSO-021, a first-in class covalent inhibitor of mitochondrial peroxiredoxin 3 (PRX3), in patients with malignant pleural effusion due to mesothelioma and other advanced solid tumors (MITOPE)
Fennell, Dean Anthony, Dulloo, Sean, Lord, Simon, Thistlethwaite, Fiona, Blyth, Kevin G, Szlosarek, Peter Wojciech, Maskell, Nick, Popat, Sanjay, Aujayeb, Avinash, Aktas, Burak Y, Javed, Sohail Rooman, Herrero Colomina, Julio, Cunniff, Brian, Duncan, Jarrett, Graham, Philippa, Bexon, Alice Susannah, Naumov, George N, Spicer, James F.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Optimization of Voyager V1 (VV1) oncolytic virus systemic delivery in combination with cemiplimab and ipilimumab in patients with melanoma and non–small cell lung cancer (NSCLC)
Lutzky, Jose, Marron, Thomas Urban, Powell, Steven Francis, Johnson, Daniel H., Patel, Manish, El-Khoueiry, Anthony B., Sarantopoulos, John, Dadi-Mehmetaj, Saida, Russell, Luke, Russell, Stephen J., Peng, Kah Whye, Kaesshaefer, Stephen, Gullo, Giuseppe, Bexon, Alice Susannah, Sznol, Mario
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Efficacy proof-of-concept from a phase 1 study of a novel therapeutic peptide, ST101, targeting the oncogenic transcription factor C/EBPβ in patients with refractory solid tumors
Evans, T.R. Jeffry, Lakhani, Nehal J., Arkenau, Hendrik-Tobias, McKean, Meredith, Symeonides, Stefan N., Iwamoto, Fabio Massaiti, Rotolo, Jim, Capiaux, Gina, Michel, Rob, Kaesshaefer, Stephen, Bexon, Alice Susannah, Falchook, Gerald Steven
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Abstract LB-140: Phase 1b/2 study of an intratumoral TLR9 agonist spherical nucleic acid (AST-008) and pembrolizumab: Evidence of immune activation
Milhem, Mohammed M., Perez, Cesar A., Hanna, Glenn J., Wise-Draper, Trisha M., Bhatia, Shailender, Bexon, Alice S., Daniel, Weston L., O'Day, Steven J.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
CTNI-49. PHASE 1 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN ß, IN PATIENTS WITH ADVANCED SOLID TUMORS, WITH A PHASE 2 EXPANSION IN RECURRENT GLIOBLASTOMA MULTIFORME
Symeonides, Stefan, Evans, Jeff, Arkenau, Hendrik-Tobias, McKean, Meredith, Lakhani, Nehal, Lim, Emerson, Falchook, Gerald, Rotolo, Jim, Capiaux, Gina, Michel, Rob, Kaesshaefer, Stephen, Bexon, Alice
Published in Neuro-oncology (Charlottesville, Va.) (12.11.2021)
Published in Neuro-oncology (Charlottesville, Va.) (12.11.2021)
Get full text
Journal Article
CTNI-49. EARLY SIGNAL OF ACTIVITY FROM A PHASE 2 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN Β (C/EBPΒ), IN RECURRENT GLIOBLASTOMA (GBM)
Iwamoto, Fabio, Gondi, Vinai, Butowski, Nicholas, Falchook, Gerald, Williams, Anja, Peters, Katherine B, Evans, Jeff, Lakhani, Nehal, McKean, Meredith, Symeonides, Stefan, Ellingson, Benjamin, Rotolo, Jim, Capiaux, Gina, Wiegert, Erol, Michel, Rob, Kaesshaefer, Steve, Bexon, Alice
Published in Neuro-oncology (Charlottesville, Va.) (14.11.2022)
Published in Neuro-oncology (Charlottesville, Va.) (14.11.2022)
Get full text
Journal Article